title: Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma.
authors.affiliation: Department of Medical Oncology, Hospital Universitario del Río Hortega, Valladolid, Spain. Electronic address: asrubiales@gmail.com.
authors.forename: Alvaro
authors.initials: A
authors.lastname: Sanz Rubiales
authors.affiliation: Department of Medical Oncology, Hospital Universitario del Río Hortega, Valladolid, Spain.
authors.forename: Virginia
authors.initials: V
authors.lastname: de la Cruz
authors.affiliation: Intensive Care Unit, Hospital Universitario del Río Hortega, Valladolid, Spain.
authors.forename: José Ángel
authors.initials: JÁ
authors.lastname: Berezo
authors.affiliation: Pathology Department, Hospital Universitario del Río Hortega, Valladolid, Spain.
authors.forename: María Ángeles
authors.initials: MÁ
authors.lastname: Torres
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy / Q000503:physiopathology*; D000368:Aged; D001980:Bronchi / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D001982:Bronchial Diseases / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology*; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use*; D013902:Radiography, Thoracic
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib